Drug Endangered Children Program and Licit Drug Diversion and Abuse Program

The Congressionally Recommended Awards Program, authorized by the Department of Justice Appropriations Act, 2010 (Pub. L. 111-117), helps improve the functioning of the criminal justice system, prevent or combat juvenile delinquency, and/or assist victims of crime (other than compensation). Funds should be used for the projects recommended by Congress, in the amounts specified in the joint explanatory statement incorporated by reference into Pub. L. 111-117, and generally consistent with one or more of the following statutory purposes: improving the functioning of the criminal justice system, preventing or combating juvenile delinquency, or assisting victims of crime (other than compensation). Each of these purposes is framed using language drawn, respectively, from the former Byrne discretionary statute, the Juvenile Justice and Delinquency Prevention Act, the Victims of Crime Act, and the Violence Against Women Act. This project is authorized and funded through a line item in the FY 2010 Congressional Budget and by the joint explanatory statement that is incorporated by reference into the FY 2010 Department of Justice Appropriations Act.

The Iowa Governor's Office of Drug Control Policy will provide training and technical assistance and sub-grants to Iowa communities with drug-endangered children (DEC) teams, as well as to enhance the Licit Drug Diversion and Abuse Program (LDDAP) for investigating and prosecuting individuals or groups diverting legal medications for inappropriate or illicit uses. The Iowa Governor's Office of Drug Control Policy will support to as many as 24 local DEC teams. They will also host a statewide DEC conference and work to support the establishment of four new DEC teams. For the LDDAP portion of the project, the grantee will hire a full-time Drug Diversion Special Agent in the Iowa Department of Public Safety, Division of Narcotics Enforcement. This grant will pay the agent's salary for one year. The grant recipient will conduct a variety of presentations to law enforcement, health care practitioners, and pharmacists on prescription and over-the-counter drug abuse and diversion. This will include topics like, the types of medicines that are being diverted and how the quantities of legitimate products being purchased might be indicative of drug diversion.

NCA/NCF